ABG
ACAD icon

Ally Bridge Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Ally Bridge Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-474,741
Closed -$7.56M – 19
2022
Q4 		$7.56M Buy
+474,741
New +$7.56M 7.35% 3